blindness from glp-1 meds and vision: what the scary headlines DON'T say GLP-1s were huge in 2025,

I highly recommend Luis to anyone looking for a specialist

hemoglobin)

In this retrospective cohort study, the TriNetX platform inherently manages missing data and patient follow-up based on the practices of contributing healthcare organizations

Unlike semaglutide and other GLP-1 agonists, sermorelin-related nausea is uncommon and rarely persistent

Some approaches highly prioritize decreasing the false positive rates even if it also causes a decrease in the number of total predictions or the true positive rate

The new approval allows Mounjaro to be used as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27-30 kg/m) with at least one weight-related comorbidity such as hypertension, dyslipidemia, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease